Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Trinity Biotech PLC as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +4 vs. Q3 2024
- Shares held
- 2.61M
- −70.8K (−2.6%) vs. Q3 2024
- Total value
- $2.30M
- −$645.5K (−21.9%) vs. Q3 2024
- New holders
- 9
- 1 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRIB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $379.5K |
| Q1 2026 | 23 | $588.9K |
| Q4 2025 | 27 | $673.3K |
| Q3 2025 | 28 | $2.81M |
| Q2 2025 | 25 | $1.66M |
| Q1 2025 | 27 | $468.1K |
| Q4 2024 | 23 | $2.30M |
| Q3 2024 | 19 | $2.95M |
| Q2 2024 | 20 | $5.67M |
| Q1 2024 | 19 | $5.95M |
| Q4 2023 | 26 | $2.58M |
| Q3 2023 | 20 | $4.49M |
| Q2 2023 | 20 | $5.93M |
| Q1 2023 | 20 | $5.96M |
| Q4 2022 | 20 | $6.51M |
| Q3 2022 | 21 | $7.50M |
| Q2 2022 | 20 | $8.92M |
| Q1 2022 | 22 | $9.56M |
| Q4 2021 | 21 | $7.70M |
| Q3 2021 | 23 | $11.9M |
| Q2 2021 | 29 | $16.6M |
| Q1 2021 | 34 | $20.3M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Trinity Biotech PLC; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Transce3nd, LLC | 3 | $3 | 0.00% | +3 | New |
| GWM Advisors LLC | 6 | $5 | 0.00% | +6 | New |
| Atwood & Palmer Inc | 20 | $18 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 222 | $191 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 240 | $211 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 468 | $412 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,432 | $1.00K | 0.00% | +1,432 | New |
| Rhumbline Advisers | 1,807 | $1.59K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,160 | $1.90K | 0.00% | −500−18.8% | Reduced |
| Clearstead Advisors, LLC | 10,000 | $8.80K | 0.00% | +10,000 | New |
| UBS Group AG | 10,621 | $9.35K | 0.00% | +10,621 | New |
| Inspirion Wealth Advisors, LLC | 10,000 | $9.45K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 12,483 | $11.0K | 0.00% | +12,483 | New |
| GAMMA Investing LLC | 13,289 | $11.7K | 0.00% | +13,289 | New |
| Geode Capital Management, LLC | 17,675 | $15.6K | 0.00% | +17,675 | New |
| Becker Capital Management Inc | 18,000 | $15.8K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 22,280 | $20.0K | 0.00% | 00.0% | Unchanged |
| Moss Adams Wealth Advisors LLC | 25,666 | $22.6K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 26,350 | $23.2K | 0.00% | +26,350 | New |
| Whitefort Capital Management, LP | 81,902 | $72.1K | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 189,053 | $166.4K | 0.00% | −61,100−24.4% | Reduced |
| Hunter Associates Investment Management LLC | 378,590 | $334.0K | 0.05% | +18,780+5.2% | Added |
| Perceptive Advisors LLC | 1,790,000 | $1.58M | 0.04% | −10,000−0.6% | Reduced |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −41,839−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −34,030−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,804−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,151−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |